Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Bruna V. Jardim‐Perassi, Mateus Repolês Lourenço, Gabriel Mandarini Doho, et al.
Anti-Cancer Agents in Medicinal Chemistry (2016) Vol. 16, Iss. 3, pp. 347-358
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Melatonin for the prevention and treatment of cancer
Ya Li, Sha Li, Yue Zhou, et al.
Oncotarget (2017) Vol. 8, Iss. 24, pp. 39896-39921
Open Access | Times Cited: 332
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Federica Lo Sardo, Paola Muti, Giovanni Blandino, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1913-1913
Open Access | Times Cited: 177
Role of melatonin in controlling angiogenesis under physiological and pathological conditions
Qiang Ma, Russel J. Reıter, Yundai Chen
Angiogenesis (2019) Vol. 23, Iss. 2, pp. 91-104
Closed Access | Times Cited: 146
Melatonin decreases breast cancer metastasis by modulating Rho‐associated kinase protein‐1 expression
Thaiz F. Borin, Ali S. Arbab, Gabriela Bottaro Gelaleti, et al.
Journal of Pineal Research (2015) Vol. 60, Iss. 1, pp. 3-15
Open Access | Times Cited: 122
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
Clinical & Translational Oncology (2018) Vol. 21, Iss. 3, pp. 268-279
Closed Access | Times Cited: 121
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Keywan Mortezaee, Masoud Najafi, Bagher Farhood, et al.
Life Sciences (2019) Vol. 228, pp. 228-241
Closed Access | Times Cited: 117
Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines
Naiane do Nascimento Gonçalves, Jucimara Colombo, Juliana Ramos Lopes, et al.
PLoS ONE (2016) Vol. 11, Iss. 3, pp. e0150407-e0150407
Open Access | Times Cited: 104
Melatonin as a potential anticarcinogen for non-small-cell lung cancer
Zhiqiang Ma, Yang Yang, Chongxi Fan, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 46768-46784
Open Access | Times Cited: 99
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Nasser Hashemi Goradel, Mohammad Hossein Asghari, Milad Moloudizargari, et al.
Toxicology and Applied Pharmacology (2017) Vol. 335, pp. 56-63
Closed Access | Times Cited: 96
Role and Therapeutic Potential of Melatonin in Various Type of Cancers
Sangiliyandi Gurunathan, Muhammad Qasim, Min-Hee Kang, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 2019-2052
Open Access | Times Cited: 73
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Saeed Mehrzadi, Mohammad Hossein Pourhanifeh, Alireza Mirzaei, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 65
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
Yukari Shirai, Christalle C. T. Chow, Gouki Kambe, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2813-2813
Open Access | Times Cited: 57
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 5, pp. 5613-5627
Closed Access | Times Cited: 78
Melatonin as an anti-inflammatory agent in radiotherapy
Masoud Najafi, Alireza Shirazi, Elahe Motevaseli, et al.
Inflammopharmacology (2017) Vol. 25, Iss. 4, pp. 403-413
Closed Access | Times Cited: 74
Melatonin: A Potential Therapeutic Option for Breast Cancer
Xiangyi Kong, Ran Gao, Zhongzhao Wang, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 11, pp. 859-871
Closed Access | Times Cited: 55
Fucoidan/chitosan layered PLGA nanoparticles with melatonin loading for inducing intestinal absorption and addressing triple-negative breast cancer progression
Yu-Wei Yen, Yi-Lin Lee, Lu-Yi Yu, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126211-126211
Closed Access | Times Cited: 18
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
Yohan Ricci Zonta, Marcelo Martinez, Isabel Cristina Cherici Camargo, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 763-763
Open Access | Times Cited: 59
Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies
Jéssica H.M. Marques, André Lupp Mota, Jéssica Gisleine de Oliveira, et al.
Life Sciences (2018) Vol. 208, pp. 131-138
Open Access | Times Cited: 56
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR‐200b down‐regulation
Nan Wu, Fanyin Meng, Tianhao Zhou, et al.
The FASEB Journal (2017) Vol. 31, Iss. 10, pp. 4305-4324
Open Access | Times Cited: 50
Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer
Jéssica Zani Lacerda, Lívia Carvalho Ferreira, Beatriz Camargo Lopes, et al.
MicroRNA (2019) Vol. 8, Iss. 3, pp. 237-247
Closed Access | Times Cited: 48
Melatonin: an endogenous miraculous indolamine, fights against cancer progression
Saptadip Samanta
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 8, pp. 1893-1922
Closed Access | Times Cited: 43
Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
Alicia González, Carolina Alonso‐González, Alicia González-González, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3263-3263
Open Access | Times Cited: 37
Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
Bianca Lara Venâncio de Godoy, Marina Gobbe Moschetta‐Pinheiro, Luiz Gustavo de Almeida Chuffa, et al.
Life Sciences (2023) Vol. 324, pp. 121708-121708
Closed Access | Times Cited: 14
The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
Nazila Fathi Maroufi, Nima Ashouri, Zohreh Mortezania, et al.
Pathology - Research and Practice (2020) Vol. 216, Iss. 10, pp. 153226-153226
Closed Access | Times Cited: 36
Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight
Yiran Li, Sze Wan Hung, Ruizhe Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 4087-4087
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top